Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CYCLOSPORINE vs NILOTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CYCLOSPORINE vs NILOTINIB: Safety Overview

Metric CYCLOSPORINE NILOTINIB
Total FAERS Reports 68,304 23,171
Deaths Reported 9,332 4,543
Death Rate 13.7% 19.6%
Hospitalizations 14,257 4,846
Average Patient Age 45.2 yrs 56.5 yrs
% Female Patients 56.5% 47.7%
FDA Approval Date Aug 14, 2018 Dec 15, 2025
Manufacturer Santen Incorporated Novadoz Pharmaceuticals LLC
Route OPHTHALMIC ORAL
Marketing Status Prescription Prescription